Feb 25, 2026 06:40AM
Feb 24, 2026 05:15PM
Feb 24, 2026 07:05AM
Feb 10, 2026 07:00AM
Jan 12, 2026 07:00AM
Oct 30, 2025 08:17AM
Oct 30, 2025 07:05AM Apellis Pharmaceuticals Reports Third Quarter 2025 Financial Results
Oct 16, 2025 07:00AM
Jul 31, 2025 07:09AM
Jul 31, 2025 07:05AM
Jul 24, 2025 07:00AM
Jul 10, 2025 07:28AM
May 25, 2025 03:00PM
May 9, 2025 05:16AM Raymond James Downgrades Apellis Pharmaceuticals (APLS) to Outperform
May 7, 2025 07:08AM
May 7, 2025 07:00AM
Apr 30, 2025 07:00AM
Mar 3, 2025 07:56AM
Feb 28, 2025 07:11AM
Feb 28, 2025 07:05AM
Feb 14, 2025 07:00AM Apellis Pharmaceuticals to Host Conference Call on February 28, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results
Jan 13, 2025 09:07AM
Jan 13, 2025 09:00AM
Nov 6, 2024 07:47AM
Nov 5, 2024 07:14AM
Nov 5, 2024 07:05AM
Oct 22, 2024 07:00AM
Aug 1, 2024 07:05AM Apellis Pharmaceuticals Reports Second Quarter 2024 Financial Results
Jul 18, 2024 07:00AM
May 7, 2024 07:59AM
May 7, 2024 07:18AM
May 7, 2024 07:05AM
Apr 30, 2024 12:35PM
Apr 29, 2024 06:42AM
Apr 23, 2024 07:00AM Apellis Pharmaceuticals to Host Conference Call on May 7, 2024, to Discuss First Quarter 2024 Financial Results
Mar 4, 2024 08:45AM
Feb 27, 2024 07:05AM
Feb 20, 2024 07:00AM
Dec 4, 2023 05:32PM
Nov 1, 2023 07:12AM
Nov 1, 2023 07:05AM
Oct 25, 2023 07:00AM Apellis Pharmaceuticals to Host Conference Call on November 1, 2023, to Discuss Third Quarter 2023 Financial Results
Oct 2, 2023 02:26PM
Sep 22, 2023 09:00PM
Aug 29, 2023 03:16PM
Aug 29, 2023 06:58AM
Aug 29, 2023 06:58AM
Aug 23, 2023 07:51AM
Aug 11, 2023 09:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Eos, Apellis, Party City, and Hayward and Encourages Investors to Contact the Firm
Jul 31, 2023 07:10AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All